An updated clinical practice guideline on the best types and amounts of medications to treat seasonal allergic rhinitis has been published in Annals of Allergy, Asthma and Immunology.
“The Joint Task Force on Practice Parameters (JTFPP) formed a workgroup to develop a focused, systematic review to provide guidance to health care providers for the treatment of seasonal allergic rhinitis (SAR) in patients under the age of 12,” says allergist Dana Wallace, MD, past ACAAI president and co-author of the guideline.
According to Wallace, the guidelines focus on three key clinical statements:
- 1. For initial treatment of SAR in adults, clinicians should routinely prescribe monotherapy with an intranasal corticosteroid (INCS) rather than INCS in combination with an oral antihistamine.